The size of the dental bone graft substitutes market in North America is estimated to grow USD 252.26 million by 2026 from USD 159.51 million in 2021, showcasing a 9.6% CAGR between 2021 to 2026.
DRIVERS
Across North America, the market for dental bone graft substitutes is growing rapidly and the main reason is the increasing aging of the population. Other factors influencing the growth of dental bone graft substitutes market are increasing technological development and availability of different kinds of bone graft varieties such as autografts, xenografts, synthetic bone alloplasts / grafts and allografts.
The growing number of general dentist who use implants is driving dental bone graft substitutes market by increasing the number of dental implant procedures. The high reimbursement rate and market players are putting pressure on prices due to the rapid use and growth of technology. The factors driving the growth of dental bone graft substitutes market are the increase in the number of dental implant procedures and people's awareness of oral care and other dental treatment modalities. Awareness about latest developed artificial bone graft products that can promote good prognosis for dental diseases is driving the growth rate of dental graft substitutes market.
RESTRAINTS
However, the risk and complications of bone grafting procedures and the high cost of manufacturing bone graft may hinder the market growth during the forecast period.
OPPORTUNITIES
The growth of the dental bone graft substitutes market in the U.S will be given new opportunities with continuous technological developments for companies to introduce new products with better results to increase ease of use and patient comfort. It can be observed that new product launches, especially in platelet rich bone grafts such as the barrier membranes products, will increase the Average Selling Prices (ASP) and overall market value, thereby providing better market growth opportunities.
CHALLENGES
The main challenge in this market is the cost of treatment. The duration of dental treatment is affected by the cost of the surgery, which in turn affects the expanding dental bone graft substitutes market in North America.
This research report on the North America Dental Bone Graft Substitutes Market has been segmented and sub-segmented into the following categories:
By Type:
By Application:
By Product:
By Country:
REGIONAL ANALYSIS
The North American dental bone graft market is dominated by the United States due to the increase in healthcare spending which helps to strengthen the market growth in this region. As a transition occurs in the use of bone graft types for various restorative and reconstructive dental procedures, the world is embracing new technologies leading to massive market growth. The US dental bone graft substitutes (DBGS) market size is expected to gain approximately $ 396 million with the fastest CAGR for alloplast bone graft products. Despite COVID19, the size of the US market is expected to increase over the forecast period to exceed $ 545 million in 2027. Over 45% of the North America dental bone graft substitutes market share in the United States will be dominated by three major bone grafts manufacturing companies.
Market growth in the Canadian region is increasing due to increased public spending on oral health and an aging population in this region. Canada follows the United States in terms of dental bone graft substitutes market share in North America. The growth of medical tourism and the favorable government measures are mainly driving the growth of the market in North America.
Companies playing a dominant role in the North America Dental Bone Graft Substitutes Market profiled in this report are Institut Straumann AG (Switzerland), Geistlich (Switzerland), DENTSPLY International (U.S.), Zimmer Biomet (U.S.), Medtronic (Ireland), BioHorizons IPH, Inc. (U.S.), ACE Surgical Supply Company, Inc. (U.S.), RTI Surgical, Inc. (U.S.), LifeNet Health (U.S.), and Dentium (Korea).
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type
5.1.1 Introduction
5.1.2 Synthetic bone graft
5.1.3 Xenograft
5.1.4 Allograft
5.1.5 Demineralized allograft
5.1.6 Y-o-Y Growth Analysis, By Type
5.1.7 Market Attractiveness Analysis, By Type
5.1.8 Market Share Analysis, By Type
5.2 Application
5.2.1 Introduction
5.2.2 Socket Preservation
5.2.3 Ridge Augmentation
5.2.4 Periodontal Defect Regeneration
5.2.5 Implant Bone Regeneration
5.2.6 Sinus lift
5.2.7 Y-o-Y Growth Analysis, By Application
5.2.8 Market Attractiveness Analysis, By Application
5.2.9 Market Share Analysis, By Application
5.3 Product
5.3.1 Introduction
5.3.2 Bio OSS
5.3.3 Osteograf
5.3.4 Grafton
5.3.5 Others
5.3.6 Y-o-Y Growth Analysis, By Product
5.3.7 Market Attractiveness Analysis, By Product
5.3.8 Market Share Analysis, By Product
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Type
6.1.3.3 By Application
6.1.3.4 By Product
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Type
6.1.4.3 By Application
6.1.4.4 By Product
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Type
6.1.5.3 By Application
6.1.5.4 By Product
6.2 United States
6.3 Canada
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Institut Straumann AG
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Geistlich
8.3 DENTSPLY International
8.4 Zimmer Biomet
8.5 Medtronic
8.6 BioHorizons IPH, Inc.
8.7 ACE Surgical Supply Company, Inc.
8.8 RTI Surgical, Inc.
8.9 LifeNet Health
8.10 Dentium
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
